Full assistance for small- and mid-sized firms eyed

Published: 2002-04-19 06:58:00

Updated: 2002-04-19 06:58:00

The Korean Drug Association (KDA) says it will make this year for concentrating efforts to actually support the small-and mid-sized firms through offerings of a low-interest fund and discounting of a bill, in a move to cope with their financial difficulties under the current system of separating ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK